Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_assertion type Assertion NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_head.
- NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_assertion wasGeneratedBy ECO_0000203 NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_provenance.
- NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_assertion wasDerivedFrom befree-20150227 NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_provenance.
- NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_assertion SIO_000772 18385010 NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_provenance.
- NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_assertion evidence source_evidence_literature NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_provenance.
- NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_assertion description "[Sixteen single nucleotide polymorphisms (SNPs) (CYP3A4*1B A>G, CYP3A5*3 G>A, GSTP1 313 A>G, GSTM1 deletion, GSTT1 deletion, MDR1 exon 21 G>T/A, MDR1 exon 26 C>T, MTHFR 677 C>T, MTHFR 1298 A>C, NR3C1 1088 A>G, RFC 80 G>A, TPMT 238 G>C, TPMT 460 G>A, TPMT 719 A>G, VDR intron 8 G>A, VDR FokI T>C) that have been implicated in the pharmacogenetics of ALL therapy were analyzed by TotalPlex amplification and SNP genotyping.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618991.RAzCIGcL8m2dOeT143uBstj_UodSf6p4LiFLV6ppyJMhc130_provenance.